Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma

High-risk neuroblastoma (NB) accounts for 15% of all pediatric cancer deaths. Refractory disease for high-risk NB patients is attributed to chemotherapy resistance and immunotherapy failure. The poor prognosis for high-risk NB patients demonstrates an unmet medical need for the development of new, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Catherine M., Benton, Thomas Z., Piña, Ivett, Francis, Megan J., Reyes, Leticia, Dolloff, Nathan G., Peterson, Yuri K., Woster, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945084/
https://www.ncbi.nlm.nih.gov/pubmed/36845935
http://dx.doi.org/10.1039/d2sc05749b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945084/
https://www.ncbi.nlm.nih.gov/pubmed/36845935
http://dx.doi.org/10.1039/d2sc05749b

Ejemplares similares